Overview

Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA)

Status:
NOT_YET_RECRUITING

Trial end date:
2032-03-31

Target enrollment:

Participant gender:

Summary

This study is a prospective, multi-center, single-arm, two-cohort, exploratory study, aiming to explore the effectiveness and safety of neoadjuvant treatment with weekly utidelone combined with cisplatin in breast cancer patients.

Phase:

PHASE2

Details

Lead Sponsor:

RenJi Hospital

Treatments:

Cisplatin
pertuzumab
Trastuzumab